Ronald Herbst
AstraZeneca (Netherlands)(NL)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research, Lung Cancer Treatments and Mutations, Immune Cell Function and Interaction, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → HMGB1 and RAGE in Inflammation and Cancer(2010)1,400 cited
- → Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells(2018)1,152 cited
- → Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression(2018)596 cited
- → The Immunoscore: Colon Cancer and Beyond(2019)398 cited
- → TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma(2018)353 cited
- → Targeting CD73 in the tumor microenvironment with MEDI9447(2016)283 cited
- →